MarketScreener Editorial Features Charles River Laboratories International, Inc.
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
NYSE
16:00:03 2026-08-31 EDT
|
5-day change | 1st Jan Change | ||
| 288.24 USD | -1.12% |
|
-3.46% | +44.50% |
| 08-20 | Charles River Laboratories International Insider Sold Shares Worth $599,711, According to a Recent SEC Filing | MT |
| 08-20 | Charles River, Medigen Partner on Multivalent Enterovirus Vaccine | MT |
MarketScreener Editorial Features
Search
 | Analyst recommendations: Corteva, Dollar Tree, JPMorgan, Microsoft, Palantir... | November 07, 2024 at 05:32 am |
No results match your criteria
- Stock Market
- Stocks
- CRL Stock
- News Charles River Laboratories International, Inc.
- MarketScreener Editorial Features
Select your edition
All financial news and data tailored to specific country editions
